rss
Arch Dis Child Fetal Neonatal Ed 2003;88:F444 doi:10.1136/fn.88.5.F444-a
  • LETTER

Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn

  1. A G Cleary1,
  2. B Brown1,
  3. J Minards1,
  4. J Sills1,
  5. P Bolton-Maggs2
  1. 1Royal Liverpool Children’s Hospital, Liverpool, UK; gavin.cleary@rlch-tr.nwest.nhs.uk
  2. 2Manchester Haemophilia Comprehensive Care Centre, Department of Clinical Haematology, Manchester Royal Infirmary, Oxford Road, Manchester M13 9WL, UK

      We read with interest the recent review of Gottstein and Cooke.1 Their systematic review of trials reporting treatment of infants with proven Rh and/or ABO haemolytic disease of the newborn (HDN) treated with high dose intravenous immunoglobulin (HDIVIG) and phototherapy, with phototherapy alone demonstrated that significantly fewer infants required exchange transfusion in the HDIVIG group. The authors point out that anti-D is the commonest red cell antibody responsible for HDN. We have recently treated two children both of whom developed evidence of immune haemolysis due to anti-D antibodies acquired from IVIG.

      The …

      [Full text of this article]

      This Article

      1. Extract
      2. Full text
      3. PDF

      Responses

      1. Submit a response
      2. No responses published

      Register for free content


      Free trial
      Individuals may register for a free 60 day online trial to all content.

      Free archive
      The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

      Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.